Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Frits vanRhee"'
Autor:
Syed Naqvi, Asis Shrestha, Marah Alzubi, Jawad Alrawabdeh, Sharmilan Thanendrarajan, Maurizio Zangari, Frits vanRhee, Carolina Schinke, Samer Al Hadidi
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 789-792 (2024)
Abstract Talquetamab is an approved therapy for relapsed multiple myeloma. This study examined dysgeusia and weight loss occurrences, alongside investigating symptom reversibility post‐treatment cessation. Dysgeusia was prevalent, persisting in 15%
Externí odkaz:
https://doaj.org/article/522f7477b16041b9b67794b001078928
Autor:
Asis Shrestha, Marah Alzubi, Jawad Alrawabdeh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits vanRhee, Samer Al Hadidi
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 554-559 (2024)
Abstract Talquetamab recently received approval for relapsed refractory multiple myeloma. However, there is currently no available data on how patients perform with BCMA based agents after progression on talquetamab. Herein, we present the outcome of
Externí odkaz:
https://doaj.org/article/c4e60f609498470e9d4ed1b0a87d5646
Autor:
Faris Jamal Abu Za'nouneh, Obada Ababneh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy Jr, Fenghuang Zhan, Frits vanRhee, Samer Al Hadidi
Publikováno v:
eJHaem, Vol 4, Iss 2, Pp 454-458 (2023)
Abstract The definition of high‐risk multiple myeloma (HRMM) is evolving. Use of a clear definition of HRMM in clinical trials was not previously studied. We explored the definition of HRMM in completed phase III clinical trials. There is extreme v
Externí odkaz:
https://doaj.org/article/092efc3f964b4af8aef42ba95eaf4704
Autor:
Noa Biran, Binod Dhakal, Suzanne Lentzsch, David Siegel, Saad Z. Usmani, Adriana Rossi, Cara Rosenbaum, Divaya Bhutani, David H. Vesole, Cesar Rodriguez, Ajay K. Nooka, Frits vanRhee, Lisette Stork‐Sloots, Femke deSnoo, Pritish K. Bhattacharyya, Durga Prasad Dash, Sena Zümrütçü, Martin H. vanVliet, Parameswaran Hari, Ruben Niesvizky
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 375-384 (2021)
Abstract Multiple myeloma (MM) is a heterogeneous hematologic malignancy associated with several risk factors including genetic aberrations which impact disease response and survival. Thorough risk classification is essential to select the best clini
Externí odkaz:
https://doaj.org/article/c560db62655e4754b5726b40b29caa1a
Autor:
Sharmilan Thanendrarajan, Faith E. Davies, Katherine Lusardi, Meera Mohan, Juan Carlos Rico Crescencio, Amy Buros, Carolina Schinke, Frits Vanrhee, Sandra Susanibar-Adaniya, Atul Kothari, Gareth J. Morgan, Maurizio Zangari, Mary J. Burgess
Publikováno v:
Transplant Infectious Disease. 21:e13052
Background Autologous stem cell transplantation (ASCT) is a commonly used treatment for multiple myeloma (MM). This retrospective cohort study characterizes the risk factors and outcomes associated with bacteremia following ASCT at a single center. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8cf6a4a4b0777dfc64416678660e278
https://doi.org/10.1111/tid.13052
https://doi.org/10.1111/tid.13052
Autor:
Sharmilan Thanendrarajan, Faith E. Davies, Maurizio Zangari, Darrell L. Dinwiddie, Olga Hardin, Atul Kothari, Sandra Susanibar-Adaniya, Frits Vanrhee, Joshua L. Kennedy, Juan Carlos Rico Crescencio, Gareth J. Morgan, Mary J. Burgess, Carolina Schinke, Mallikarjuna Rettiganti
Publikováno v:
Open Forum Infectious Diseases. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abcbd7b1d6f71be9a0078d5a1ba3411d
https://doi.org/10.1093/ofid/ofw194.16
https://doi.org/10.1093/ofid/ofw194.16
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
Autor:
Susann Szmania, Juan F. Vera, Dario Campana, Natalia Lapteva, Elaine Coustan-Smith, April G. Durett, Amberly Moreno-Bost, Minhtran C. Ngo, Jiali Sun, Leslie L. Huye, Adrian P. Gee, Jun Ando, Lisa Rollins, Frits Vanrhee, Cliona M. Rooney, Jian Fang, Zhuyong Mei, Tarun K. Garg, Varada Dandekar, Kimberley Jackson
Publikováno v:
Cytotherapy. 14:1131-1143
Interest in natural killer (NK) cell-based immunotherapy has resurged since new protocols for the purification and expansion of large numbers of clinical-grade cells have become available.We have successfully adapted a previously described NK expansi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee7f76f3c0b4608cbc05773776cd59f5
https://doi.org/10.3109/14653249.2012.700767
https://doi.org/10.3109/14653249.2012.700767
Autor:
Juan Carlos Rico Crescencio, Jorge Jo-Kamimoto, Sharmilan Thanendrarajan, Faith E. Davies, Maurizio Zangari, Andrew J Johnsrud, Joyce Johnsrud, Gareth J. Morgan, Carolina Schinke, Atul Kothari, Mary J. Burgess, Frits Vanrhee, Sandra Susanibar
Publikováno v:
Open Forum Infectious Diseases
Background Daratumumab is an IgG kappa monoclonal antibody (mAB) against CD38 which is expressed on myeloma cells. It has recently been approved for treatment of patients with relapsed refractory multiple myeloma. Our objective was to identify the po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5897ede65169870e3969401a94418801
https://doi.org/10.1093/ofid/ofx163.1884
https://doi.org/10.1093/ofid/ofx163.1884
Autor:
Frits Vanrhee, Mohamed H. Zaki, Peter M. Voorhees, Carlos A. Garay, Richard R. Furman, Trina Jiao, Luis Fayad, Razelle Kurzrock, Christine F. Lihou, Hossein Borghaei, Uma Prabhakar, Robert Z. Orlowski
Publikováno v:
Blood. 108:2728-2728
Background: IL-6 is a pleiotropic cytokine, the dysregulation of which plays an etiological role in many diseases. Multicentric Castleman’s disease (CD) is a polyclonal lymphoproliferative disorder in which IL-6, overproduced by enlarged lymph node
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::275625102886d3e3b924322cc50df25d
https://doi.org/10.1182/blood.v108.11.2728.2728
https://doi.org/10.1182/blood.v108.11.2728.2728